$イボーク ファーマ(EVOK.US)$ NEWS Evoke Pharma Reports First Quarter 2024 Financial Results Positive 114% year-over-year increase in net product sales to $1.7 million. 70% growth in prescriber numbers in Q1 2024 compared to Q4 2023. Net revenue guidance for 2024 reaffirmed at $14 million. Reduction in net loss to $1.6 million from $2.2 million in Q1 2023. Raised $8.8 million through a public offering in Q1 2024. Partnership with ASPN Pharmacies expected to enhance service delivery and patient reach. ...
$イボーク ファーマ(EVOK.US)$Evoke Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.7%),Altium Growth Fund, LP EIN:(9.7%), etc. SEC announcement· 1 min ago
#2023 Recap:My trading story 2023 was a year full of tears and fun. Tear because of the leak of knowledge and trade with emotional. Fun because of earning a bit at the end of 2023. Thanks to Moomoo, provided an endless course, technique to equip me with correct trading direction without any more emotional. My biggest lost is Evoke Pharma due to me as a fresh one trading with emotional. Thanks for QQQ, I gained a bit to recover my loss. Look ahead more gaining in 2024.
$イボーク ファーマ(EVOK.US)$United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI 2 MINUTES AGO, 8:30 AM EST VIA GLOBENEWSWIRE
$イボーク ファーマ(EVOK.US)$ Hello everyone, We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall? If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued! Thank you for your participation.
イボーク ファーマに関するコメント
NEWS
Evoke Pharma Reports First Quarter 2024 Financial Results
Positive
114% year-over-year increase in net product sales to $1.7 million.
70% growth in prescriber numbers in Q1 2024 compared to Q4 2023.
Net revenue guidance for 2024 reaffirmed at $14 million.
Reduction in net loss to $1.6 million from $2.2 million in Q1 2023.
Raised $8.8 million through a public offering in Q1 2024.
Partnership with ASPN Pharmacies expected to enhance service delivery and patient reach.
...
SEC announcement· 1 min ago
2023 was a year full of tears and fun. Tear because of the leak of knowledge and trade with emotional. Fun because of earning a bit at the end of 2023. Thanks to Moomoo, provided an endless course, technique to equip me with correct trading direction without any more emotional.
My biggest lost is Evoke Pharma due to me as a fresh one trading with emotional.
Thanks for QQQ, I gained a bit to recover my loss.
Look ahead more gaining in 2024.
3 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
2 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
Hello everyone,
We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall?
If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued!
Thank you for your participation.
まだコメントはありません